Le Yu

机构：Tianjin University of Commerce · ORCID：0009-0006-1015-4662

发表论文 115 篇 · 总被引 664 次 · h-index 13

代表论文

Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress (2024 · Journal of Hematology & Oncology · 被引 38)
GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy (2025 · Advanced Science · 被引 10)
A pH-Responsive Dendritic-DNA-Based Nanohydrogel for Dual Drug Delivery (2025 · Biomolecules · 被引 8)
Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy (2025 · Cell Reports Medicine · 被引 7)
Machine learning-driven programmed cell death signature for prognosis and drug candidate discovery in diffuse large B-cell lymphoma: Multi-cohort study and experimental validation (2025 · International Immunopharmacology · 被引 3)
Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma (2025 · Frontiers in Nutrition · 被引 3)